Autopsy report · NCT01045915

Safety and Efficacy Study of Electrotransfer of Plasmid AMEP to Treat Advanced or Metastatic Melanoma

“The study has been halted due to the low enrolment rate.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 6 months before it started.
• Ran for about 2 years 6 months before it stopped.
• 5 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

Valerio Therapeutics

Sponsor type

Industry

Conditions

Melanoma

Interventions

naked DNA coding for protein AMEP

Participants

5

Sites

3

Countries

Denmark, France, Slovenia

Trials that died the same way

• UCB Proof of Concept Study in Patients With Primary Sjögren's Syndrome
  “Study stopped prematurely due to enrolment challenges.” (82% match in meaning)
• OrthoPulse Gen 2 Initial Device Evaluation and Assessment of Clinical Effectiveness (CA)
  “Study stopped because slow enrolment.” (80% match in meaning)
• The Role of Osteopathic Manipulative Medicine in Recovery From Concussions
  “Due to lower than anticipated enrollment number, this study was stopped.” (79% match in meaning)
• Sorafenib-induced Hand- Foot Skin Reaction Treatment
  “Study was halted due to poor subject accrual.” (78% match in meaning)
• Hand Injected Ventriculography vs. Power Injected Left Ventriculography
  “Study was stopped due to low enrollment.” (78% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.